Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Diana N. Nunes is active.

Publication


Featured researches published by Diana N. Nunes.


Proceedings of the National Academy of Sciences of the United States of America | 2001

The contribution of 700,000 ORF sequence tags to the definition of the human transcriptome

Anamaria A. Camargo; Helena P.B. Samaia; Emmanuel Dias-Neto; Daniel F. Simão; Italo A. Migotto; Marcelo R. S. Briones; Fernando Ferreira Costa; Maria Aparecida Nagai; Sergio Verjovski-Almeida; Marco A. Zago; Luís Eduardo Coelho Andrade; Helaine Carrer; Enilza M. Espreafico; Angelita Habr-Gama; Daniel Giannella-Neto; Gustavo H. Goldman; Arthur Gruber; Christine Hackel; Edna T. Kimura; Rui M. B. Maciel; Suely Kazue Nagahashi Marie; Elizabeth A. L. Martins; Marina P. Nobrega; Maria Luisa Paçó-Larson; Maria Inês de Moura Campos Pardini; Gonçalo Amarante Guimarães Pereira; João Bosco Pesquero; Vanderlei Rodrigues; Silvia Regina Rogatto; Ismael D.C.G. Silva

Open reading frame expressed sequences tags (ORESTES) differ from conventional ESTs by providing sequence data from the central protein coding portion of transcripts. We generated a total of 696,745 ORESTES sequences from 24 human tissues and used a subset of the data that correspond to a set of 15,095 full-length mRNAs as a means of assessing the efficiency of the strategy and its potential contribution to the definition of the human transcriptome. We estimate that ORESTES sampled over 80% of all highly and moderately expressed, and between 40% and 50% of rarely expressed, human genes. In our most thoroughly sequenced tissue, the breast, the 130,000 ORESTES generated are derived from transcripts from an estimated 70% of all genes expressed in that tissue, with an equally efficient representation of both highly and poorly expressed genes. In this respect, we find that the capacity of the ORESTES strategy both for gene discovery and shotgun transcript sequence generation significantly exceeds that of conventional ESTs. The distribution of ORESTES is such that many human transcripts are now represented by a scaffold of partial sequences distributed along the length of each gene product. The experimental joining of the scaffold components, by reverse transcription–PCR, represents a direct route to transcript finishing that may represent a useful alternative to full-length cDNA cloning.


PLOS ONE | 2009

Next-Generation Phage Display: Integrating and Comparing Available Molecular Tools to Enable Cost- Effective High-Throughput Analysis

Emmanuel Dias-Neto; Diana N. Nunes; Ricardo J. Giordano; Jessica Sun; Gregory H. Botz; Kuan Yang; João C. Setubal; Renata Pasqualini; Wadih Arap

Background Combinatorial phage display has been used in the last 20 years in the identification of protein-ligands and protein-protein interactions, uncovering relevant molecular recognition events. Rate-limiting steps of combinatorial phage display library selection are (i) the counting of transducing units and (ii) the sequencing of the encoded displayed ligands. Here, we adapted emerging genomic technologies to minimize such challenges. Methodology/Principal Findings We gained efficiency by applying in tandem real-time PCR for rapid quantification to enable bacteria-free phage display library screening, and added phage DNA next-generation sequencing for large-scale ligand analysis, reporting a fully integrated set of high-throughput quantitative and analytical tools. The approach is far less labor-intensive and allows rigorous quantification; for medical applications, including selections in patients, it also represents an advance for quantitative distribution analysis and ligand identification of hundreds of thousands of targeted particles from patient-derived biopsy or autopsy in a longer timeframe post library administration. Additional advantages over current methods include increased sensitivity, less variability, enhanced linearity, scalability, and accuracy at much lower cost. Sequences obtained by qPhage plus pyrosequencing were similar to a dataset produced from conventional Sanger-sequenced transducing-units (TU), with no biases due to GC content, codon usage, and amino acid or peptide frequency. These tools allow phage display selection and ligand analysis at >1,000-fold faster rate, and reduce costs ∼250-fold for generating 106 ligand sequences. Conclusions/Significance Our analyses demonstrates that whereas this approach correlates with the traditional colony-counting, it is also capable of a much larger sampling, allowing a faster, less expensive, more accurate and consistent analysis of phage enrichment. Overall, qPhage plus pyrosequencing is superior to TU-counting plus Sanger sequencing and is proposed as the method of choice over a broad range of phage display applications in vitro, in cells, and in vivo.


Proceedings of the National Academy of Sciences of the United States of America | 2015

PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.

Ahmad Salameh; Alessandro K. Lee; Marina Cardó-Vila; Diana N. Nunes; Fernanda I. Staquicini; Andrey S. Dobroff; Serena Marchiò; Nora M. Navone; Hitomi Hosoya; Richard C. Lauer; Sijin Wen; Carolina C. Salmeron; Anh Hoang; Irene Newsham; Leandro de Araujo Lima; Dirce Maria Carraro; Salvatore Oliviero; Mikhail G. Kolonin; Richard L. Sidman; Kim Anh Do; Patricia Troncoso; Christopher J. Logothetis; Ricardo R. Brentani; George A. Calin; Webster K. Cavenee; Emmanuel Dias-Neto; Renata Pasqualini; Wadih Arap

Significance Prostate cancer has an unpredictable natural history: While most tumors are clinically indolent, some patients display lethal phenotypes. Serum prostate-specific antigen is the most often used test in prostate cancer but screening is controversial. Treatment options are limited for metastatic disease, hence the need for early diagnosis. Prostate cancer antigen 3 (PCA3), a long noncoding RNA, is the most specific biomarker identified and approved as a diagnostic test. However, its inherent biological function (if any) has remained elusive. We uncovered a negative transdominant oncogenic role for PCA3 that down-regulates an unrecognized tumor suppressor gene, PRUNE2 (a human homolog of the Drosophila prune gene) thereby promoting malignant cell growth. This work defines a unique biological function for PCA3 in prostate cancer. Prostate cancer antigen 3 (PCA3) is the most specific prostate cancer biomarker but its function remains unknown. Here we identify PRUNE2, a target protein-coding gene variant, which harbors the PCA3 locus, thereby classifying PCA3 as an antisense intronic long noncoding (lnc)RNA. We show that PCA3 controls PRUNE2 levels via a unique regulatory mechanism involving formation of a PRUNE2/PCA3 double-stranded RNA that undergoes adenosine deaminase acting on RNA (ADAR)-dependent adenosine-to-inosine RNA editing. PRUNE2 expression or silencing in prostate cancer cells decreased and increased cell proliferation, respectively. Moreover, PRUNE2 and PCA3 elicited opposite effects on tumor growth in immunodeficient tumor-bearing mice. Coregulation and RNA editing of PRUNE2 and PCA3 were confirmed in human prostate cancer specimens, supporting the medical relevance of our findings. These results establish PCA3 as a dominant-negative oncogene and PRUNE2 as an unrecognized tumor suppressor gene in human prostate cancer, and their regulatory axis represents a unique molecular target for diagnostic and therapeutic intervention.


Proceedings of the National Academy of Sciences of the United States of America | 2011

Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients

Fernanda I. Staquicini; Marina Cardó-Vila; Mikhail G. Kolonin; Martin Trepel; Julianna K. Edwards; Diana N. Nunes; Anna Sergeeva; Jessica Sun; Nalvo F. Almeida; Shi Ming Tu; Gregory H. Botz; Michael J. Wallace; David J. O'Connell; Stan Krajewski; Jeffrey E. Gershenwald; Jeffrey J. Molldrem; Anne Lederman Flamm; Erkki Koivunen; Rebecca D. Pentz; Emmanuel Dias-Neto; João C. Setubal; Dolores J. Cahill; Patricia Troncoso; Kim Ahn Do; Christopher J. Logothetis; Richard L. Sidman; Renata Pasqualini; Wadih Arap

Molecules differentially expressed in blood vessels among organs or between damaged and normal tissues, are attractive therapy targets; however, their identification within the human vasculature is challenging. Here we screened a peptide library in cancer patients to uncover ligand-receptors common or specific to certain vascular beds. Surveying ∼2.35 × 106 motifs recovered from biopsies yielded a nonrandom distribution, indicating that systemic tissue targeting is feasible. High-throughput analysis by similarity search, protein arrays, and affinity chromatography revealed four native ligand-receptors, three of which were previously unrecognized. Two are shared among multiple tissues (integrin α4/annexin A4 and cathepsin B/apolipoprotein E3) and the other two have a restricted and specific distribution in normal tissue (prohibitin/annexin A2 in white adipose tissue) or cancer (RAGE/leukocyte proteinase-3 in bone metastases). These findings provide vascular molecular markers for biotechnology and medical applications.


Oral Oncology | 2000

Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings

Diana N. Nunes; Luiz Paulo Kowalski; Andrew J.G. Simpson

Microsatellite allele losses are characteristic features of head and neck squamous cell carcinoma and can be used as molecular markers for malignancy. We have investigated the detection of microsatellite allele loss in mouth washes and lesions brushings from 19 patients with squamous cell carcinoma of the oral cavity and oropharynx as a means of tumour detection. In 84% of the analysed cases, allele loss previously identified in the tumour of these patients, was detected in these easily obtained specimens. No alterations were found in material derived from 10 healthy individuals. Success of detection was independent of tumour stage, suggesting that this approach may be useful for early diagnosis as well as for follow-up.


Trends in Cardiovascular Medicine | 2008

Beyond Receptor Expression Levels: The Relevance of Target Accessibility in Ligand-Directed Pharmacodelivery Systems

Michael G. Ozawa; Amado J. Zurita; Emmanuel Dias-Neto; Diana N. Nunes; Richard L. Sidman; Juri G. Gelovani; Wadih Arap; Renata Pasqualini

For development of a new ligand-directed pharmacology, it is critical to measure delivery of targeted drug ligands via molecular imaging or diagnostic readouts (termed theranostics). Combinatorial peptide libraries serve as unbiased functional screens that can identify specific peptides targeting cell-surface receptors accessible to the circulation. As candidate drug leads, such peptides provide motifs likely to modify ligand-receptor interactions and downstream signal transduction pathways. This strategy is synergistic with genomic and proteomic approaches and has yielded insights into the specialized nature of the target tissue microenvironment. However, for this vision to be realized, one must look, as recent literature suggests, beyond receptor levels and critically analyze ligand accessibility as a key determinant in pharmacodelivery systems.


BMC Genomics | 2007

A quantitative view of the transcriptome of Schistosoma mansoni adult-worms using SAGE

Elida B. Ojopi; Paulo S. L. Oliveira; Diana N. Nunes; Apuã C.M. Paquola; Ricardo DeMarco; Sheila P. Gregório; Karina Araújo Aires; Carlos Frederico Martins Menck; Luciana C.C. Leite; Sergio Verjovski-Almeida; Emmanuel Dias-Neto

BackgroundFive species of the genus Schistosoma, a parasitic trematode flatworm, are causative agents of Schistosomiasis, a disease that is endemic in a large number of developing countries, affecting millions of patients around the world. By using SAGE (Serial Analysis of Gene Expression) we describe here the first large-scale quantitative analysis of the Schistosoma mansoni transcriptome, one of the most epidemiologically relevant species of this genus.ResultsAfter extracting mRNA from pooled male and female adult-worms, a SAGE library was constructed and sequenced, generating 68,238 tags that covered more than 6,000 genes expressed in this developmental stage. An analysis of the ordered tag-list shows the genes of F10 eggshell protein, pol-polyprotein, HSP86, 14-3-3 and a transcript yet to be identified to be the five top most abundant genes in pooled adult worms. Whereas only 8% of the 100 most abundant tags found in adult worms of S. mansoni could not be assigned to transcripts of this parasite, 46.9% of the total ditags could not be mapped, demonstrating that the 3 sequence of most of the rarest transcripts are still to be identified. Mapping of our SAGE tags to S. mansoni genes suggested the occurrence of alternative-polyadenylation in at least 13 gene transcripts. Most of these events seem to shorten the 3 UTR of the mRNAs, which may have consequences over their stability and regulation.ConclusionSAGE revealed the frequency of expression of the majority of the S. mansoni genes. Transcriptome data suggests that alternative polyadenylation is likely to be used in the control of mRNA stability in this organism. When transcriptome was compared with the proteomic data available, we observed a correlation of about 50%, suggesting that both transcriptional and post-transcriptional regulation are important for determining protein abundance in S. mansoni. The generation of SAGE tags from other life-cycle stages should contribute to reveal the dynamics of gene expression in this important parasite.


Proteomics | 2014

The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles

Maria Amorim; Gustavo Ribeiro Fernandes; Paulo Sergio Lopes de Oliveira; Daniel Martins-de-Souza; Emmanuel Dias-Neto; Diana N. Nunes

ERBB2/HER2 amplification activates signaling cascades that lead to a tumor cell phenotype. However, despite its remarkable importance in oncology, the consequences of HER2 amplification over the extracellular vesicles (EVs) content have not yet been investigated. Here, we isolated EVs secreted by HB4a, a mammary luminal epithelial cell line and C5.2, its HER2‐overexpressing clone. We isolated two EV sets (20 and 100 K) by ultracentrifugation and used electron microscopy and nanoparticle tracking analysis for their morphological characterization. We employed GeLC‐MS/MS combined with isotope‐coded protein labeling to evaluate cell‐derived proteins and LC‐MS/MS label free spectral counting to quantify the EVs proteome. We found higher HER2 levels in both C5.2‐derived EVs when compared with C5.2 cells, suggesting its preferential shuttling. Proteins capable of inducing malignant transformation are enriched in both C5.2 EV subsets, including two HER2‐related proteins involved in cell motility and invasion, cofilin and CD44. MetaCore™ analysis indicated an enrichment of cell adhesion and cytoskeleton‐remodeling pathways in C5.2 EVs, as well as proteins related to HER2 signaling, such as sphingosine‐1‐phosphate pathway. Together, our data indicate that in terms of protein content, distinct vesicle sets reinforce and complement each other. Our results also suggest that HER2‐upregulated proteins from EVs may be relevant for cellular malignancy and can be potential biomarkers for HER2+ cancer patients.


BMC Microbiology | 2014

Alcohol and tobacco consumption affects bacterial richness in oral cavity mucosa biofilms

Andrew Maltez Thomas; Frederico Omar Gleber-Netto; Gustavo Ribeiro Fernandes; Maria Amorim; Luisa Fernanda Barbosa; Ana Lucia Noronha Francisco; Arthur Guerra de Andrade; João C. Setubal; Luiz Paulo Kowalski; Diana N. Nunes; Emmanuel Dias-Neto

BackgroundToday there are more than 2 billion alcohol users and about 1.3 billion tobacco users worldwide. The chronic and heavy use of these two substances is at the heart of numerous diseases and may wreak havoc on the human oral microbiome. This study delves into the changes that alcohol and tobacco may cause on biofilms of the human oral microbiome. To do so, we used swabs to sample the oral biofilm of 22 subjects; including 9 control-individuals with no or very low consumption of alcohol and no consumption of tobacco, 7 who were chronic and heavy users of both substances and 6 active smokers that reported no significant alcohol consumption. DNA was extracted from swabs and the V1 region of the 16S rRNA gene was PCR amplified and sequenced using the Ion Torrent PGM platform, generating 3.7 million high quality reads. DNA sequences were clustered and OTUs were assigned using the ARB SILVA database and Qiime.ResultsWe found no differences in species diversity and evenness among the groups. However, we found a significant decrease in species richness in only smokers and in smokers/drinkers when compared to controls. We found that Neisseria abundance was significantly decreased in both groups when compared to controls. Smokers had significant increases in Prevotella and Capnocytophaga and reductions in Granulicatella, Staphylococcus, Peptostreptococcus and Gemella when compared to the two other groups. Controls showed higher abundance of Aggregibacter, whilst smokers/drinkers had lower abundances of Fusobacteria. Samples from only smokers clustered closer together than to controls and smokers/drinkers, and also had a significant reduction in inter-group dissimilarity distances, indicating a more homogenous group than controls.ConclusionsOur results indicate that the continued use of tobacco or alcohol plus tobacco significantly reduces bacterial richness, which apparently leads to a reduction in inter-group variability, turning the respective biofilms into a more homogenous microenvironment in terms of bacterial community composition, with possible consequences for human oral diseases.


PLOS ONE | 2011

Poly (A)+ Transcriptome Assessment of ERBB2-Induced Alterations in Breast Cell Lines

Dirce Maria Carraro; Elisa N. Ferreira; Gustavo de Campos Molina; Renato David Puga; Eduardo Fernandes Abrantes; Adriana Priscila Trapé; Bedrich L. Ekhardt; Diana N. Nunes; Maria Mitzi Brentani; Wadih Arap; Renata Pasqualini; Helena Brentani; Emmanuel Dias-Neto; Ricardo R. Brentani

We report the first quantitative and qualitative analysis of the poly (A)+ transcriptome of two human mammary cell lines, differentially expressing (human epidermal growth factor receptor) an oncogene over-expressed in approximately 25% of human breast tumors. Full-length cDNA populations from the two cell lines were digested enzymatically, individually tagged according to a customized method for library construction, and simultaneously sequenced by the use of the Titanium 454-Roche-platform. Comprehensive bioinformatics analysis followed by experimental validation confirmed novel genes, splicing variants, single nucleotide polymorphisms, and gene fusions indicated by RNA-seq data from both samples. Moreover, comparative analysis showed enrichment in alternative events, especially in the exon usage category, in ERBB2 over-expressing cells, data indicating regulation of alternative splicing mediated by the oncogene. Alterations in expression levels of genes, such as LOX, ATP5L, GALNT3, and MME revealed by large-scale sequencing were confirmed between cell lines as well as in tumor specimens with different ERBB2 backgrounds. This approach was shown to be suitable for structural, quantitative, and qualitative assessment of complex transcriptomes and revealed new events mediated by ERBB2 overexpression, in addition to potential molecular targets for breast cancer that are driven by this oncogene.

Collaboration


Dive into the Diana N. Nunes's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wadih Arap

University of New Mexico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anamaria A. Camargo

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Andrew J.G. Simpson

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ricardo R. Brentani

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge